Qualcomm's still the best way to play chips
Regardless of which company comes out on top in the mobile device race, the chipset maker wins.
A big deal was made when, in the April quarter, Qualcomm (QCOM) management issued guidance that was below Street expectations. Investors immediately began to panic, suggesting Qualcomm's reign over the chip industry was coming to an abrupt end. There were also rumblings about threats to Qualcomm's chipset margins, which had come under pressure.
It was clear that the average selling price (ASP) of mobile devices were not as stout as they once were. After two years of strong growth, prices were beginning to come down, spurring more investor anxiety about high-end device saturation. This had a direct impact to not only Qualcomm, but also rivals including Broadcom (BRCM). But even though shares of Qualcomm had fallen almost 10% since reaching a high of $67.65 in April, I never believed that it was time to worry (TheStreet).
What I have always known is that, despite how weak the numbers look, Qualcomm's results were always better than the closest rival. With each passing quarter, there was no question that Qualcomm is still winning the device battles by a greater margin. This means that as long as the mobile devices race continues between Apple (AAPL) and Samsung (SSNLF), Qualcomm wins either way. And this recent quarter, during which Qualcomm posted 35% year-over-year revenue growth, was a perfect example.
By contrast, Broadcom, which I've always considered the second best within the sector, posted growth of only 6%, which missed estimates. Qualcomm, meanwhile, was able to beat estimates by 3%, helped by a strong showing in its chip business, which surged almost 50% year over year. The company benefited from a slight recovery in ASPs and strong unit shipments. I referenced this earlier: It's no coincidence that Apple also surprised the Street with higher-than-expected iPhone sales.
Here, too, Qualcomm is outperforming Texas Instruments (TXN), which posted nearly a 9% decline in revenue, making this now the seventh consecutive quarter of year-over-year declines. But despite the stark contrast in operational performance, Texas Instruments still enjoys a price-to-earnings ratio that is four points higher than Qualcomm, which suggests that investors are still expecting more from Texas Instruments.
Without question, the pursuit for mobile device supremacy is the hottest battle on the market today. But Texas Instruments has exited that business altogether. I think it's a mistake for investors to discount Qualcomm's long-term potential based on near-term headwinds. Plus, let's not take for granted that Qualcomm continues to reinvest heavily in research and development.
Management wants to make sure that Qualcomm's chip technology remains the top choice for not only Apple, but also Samsung and anyone else that is looking to grow market share. What's more, given that Apple is rumored to launch several new devices later this year, presumably a cheaper iPhone and a new iPad, Qualcomm should see more market share gain over the next couple of quarters.
The key here, though, is the cheaper or "budget" iPhone, as it is often referred. Unlike, Broadcom and say, Nvidia (NVDA), Qualcomm has built a smartphone chip that works on multiple frequencies at the same time. This has been one of the hiccups rumored to prevent Apple from taking advantage of growth opportunities in China. With Qualcomm's chip and a budget iPhone, I have to expect that for both companies, the best is yet to come.
This is one of several examples of why I continue to believe in Qualcomm's business and the stock, which seems cheap at current levels. I would be adding shares until the company shows meaningful signs of slowing growth. The stock has enough momentum to reach $75 to $80 by the end of the year -- if, for no other reason than the fact that regardless of who comes out on top in the mobile race, Qualcomm wins.
At the time of publication, the author was long AAPL.
More from TheStreet.com
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Obamacare isn't the only reform hitting the US health industry. One company is emerging as a stronger player after recent struggles.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.